Cargando…
RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review
The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin family that is overexpressed in several cancers. RAGE is highly expressed in the lung, and its expression increases proportionally at the site of inflammation. This receptor can bind a variety of ligands, inclu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820344/ https://www.ncbi.nlm.nih.gov/pubmed/36613714 http://dx.doi.org/10.3390/ijms24010266 |